Clinical Trial Update: Iron Supplementation of Lead-exposed Infants [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating iron supplementation in lead-exposed infants has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lead Poisoning

Drugs mentioned

• Iron supplement

Snippet

Sponsor: Cornell University | Conditions: Lead Toxicity | Phase 2 | Status: COMPLETED